Ketamine: A Paradigm Shift for Depression Research and Treatment
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019
The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis
Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019
A systematic study of microdosing psychedelics
Polito, V., & Stevenson, R. J. | PloS one | 6 February 2019
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 25 January 2019
Neurochemical models of near-death experiences: A large-scalestudy based on the semantic similarity of written reports
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., & Tagliazucchi, E. | Consciousness and cognition | 20 January 2019
The effects of ketamine on suicidality across various formulations and study settings
Dadiomov, D., & Lee, K. | Mental Health Clinician | 4 January 2019
Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.
Schenk, S., & Newcombe, D. | Journal of clinical psychopharmacology | 12 December 2018
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats
Hake, H. S., Davis, J. K., Wood, R. R., Tanner, M. K., Loetz, E. C., Sanchez, A., ... & Greenwood, B. N. | Physiology & behavior | 4 December 2018
Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018
Psychiatry might need some psychedelic therapy
Johnson, M. W. | International Review of Psychiatry | 3 December 2018
Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence
Knuijver, T., Belgers, M., Markus, W., Verkes, R. J., van Oosteren, T., & Schellekens, A. | Journal of clinical psychopharmacology | 1 December 2018
Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.
Schenk, S., & Newcombe, D. | Journal of clinical psychopharmacology | December 2018
An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders
Renelli, M., Fletcher, J., Tupper, K. W., Files, N., Loizaga-Velder, A., & Lafrance, A. | Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity | 24 November 2018
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | 13 November 2018
Acute effects of ayahuasca in a juvenile non-human primate model of depression
da Silva, F. S., Silva, E. A., Sousa Jr, G. M. D., Maia-de-Oliveira, J. P., Soares-Rachetti, V. D. P., de Araujo, D. B., ... & Galvão-Coelho, N. L. | Brazilian Journal of Psychiatry | 8 November 2018
Predicting Responses to Psychedelics: A Prospective Study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Russ, S., Nutt, D., ... & Carhart-Harris, R. L. | Frontiers in pharmacology | 2 November 2018
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study
Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., ... & Reigstad, K. | Journal of child and adolescent psychopharmacology | 1 November 2018
Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.
Bodnár, K. J., & Kakuk, P. | Medicine, Health Care and Philosophy | 16 October 2018
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Lyons, T., & Carhart-Harris, R. L. | Frontiers in psychology | 12 October 2018
Ketamine and depression
Hirota, K. and Lambert, D. | British Journal of Anaesthesia | 12 October 2018 |
Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
Corkery, J. M. | Progress in brain research | 12 October 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Kivell, B., Paton, K., Kumar, N., Morani, A., Culverhouse, A., Shepherd, A., ... & Prisinzano, T. | Molecules | 11 October 2018
DARK Classics in Chemical Neuroscience: Ibogaine.
Wasko, M. J., Witt-Enderby, P. A., & Surratt, C. K. | ACS chemical neuroscience | 9 October 2018